COVID’s Genetic Code Was Patented by Moderna Three Years Before Pandemic Began: Researchers

The spike protein found in SARS-CoV-2 contains a sequence identical to a genetic code linked to a piece of a gene patented by Moderna three years before the pandemic emerged, researchers found.

  • An international team of researchers published a study in Frontiers in Virology, finding that the furin cleavage site (FCS) of SARS-CoV-2 holds a small amount of genetic code that replicates a part of a gene the pharmaceutical company Moderna patented in 2016.
  • The researchers argue that because the chance of Moderna’s sequence randomly appearing naturally is 1 in 3 trillion, COVID may very well have been mutated in a lab experiment, InfoWars reported.
  • “The presence in SARS-CoV-2 of a 19-nucleotide RNA sequence encoding an FCS at amino acid 681 of its spike protein with 100% identity to the reverse complement of a proprietary MSH3 mRNA sequence is highly unusual,” researchers said in the study.

“The researchers also found genetic material from Chinese hamsters and green monkeys, which may suggest the virus was being examined in a lab, using either the animals themselves or their cells.”

  • CEO of Pfizer, Albert Bourla, recently admitted their mRNA vaccine was developed based on a lab-manufactured version of COVID rather than one that was found naturally.
  • “The data we received are data that they got from what we call a pseudovirus, so it’s not the real virus,” Bourla said. “It is a virus that we have constructed in our labs and it is identical with the Omicron virus.”
  • This data joins the list of evidence that contradicts NIAID Director Anthony Fauci’s original explanation of how the virus originated from bats.